Kochanski & Partners has advised Polska Wytwornia Papierow Wartosciowych on the acquisition of a greenfield site of more than 17 hectares in Warsaw from Polfa Tarchomin for PLN 143 million.
PWPW is a producer of banknotes ordered by the National Bank of Poland and central banks of other countries.
Tarchominskie Zaklady Farmaceutyczne Polfa in Warsaw describes itself as one of the largest generic companies operating in Poland and one of the oldest pharmaceutical producers in the world, with a history dating back to 1823 and the production of the first medicinal preparations.
According to Kochanski & Partners, “the land will be used for the construction of a state-of-the-art banknote printing and security paper facility. This is one of the largest transactions on the Polish real estate market in recent years. The investment will enable the implementation of PWPW’s long-term strategic business plan and meet the needs arising from the limitations of the company’s current headquarters.”
According to the firm, “it is also a strategic transaction for Poland, as the products manufactured at the new plant will be of key importance to the country. In return, TZF Polfa has raised the funds necessary to complete the construction of Poland’s first and most modern Oncology Drug Development and Production Centre in our region. The total value of the investment is approximately PLN 550 million.”
The Kochanski & Partners team included Partners Pawel Cholewinski and Wojciech Wrochna, Counsels Weronika Duda and Malwina Jagiello, Senior Associate Agata Tworzydlo, and Associates Dominik Grys and Paulina Majewska.
Kochanski & Partners did not respond to our inquiry on the matter.
